Keynote Information

PLENARY KEYNOTE PROGRAM

  • Tuesday, February 23, 2016: PATIENT-SITE-SPONSOR-COMMUNITY VOICES: ENGAGING THE CUSTOMER, BUILDING TRUST AND FURTHERING RESEARCH
  • Wednesday, February 24, 2016: ADVANCING CLINICAL RESEARCH WITH TECHNOLOGY AND INNOVATION
 

Day 1 Plenary Keynote | Day 2 Plenary Keynote


Tuesday, February 23, 2016

OPENING PLENARY KEYNOTES
PATIENT-SITE-SPONSOR-COMMUNITY VOICES: ENGAGING THE CUSTOMER, BUILDING TRUST AND FURTHERING RESEARCH

7:30 am Registration and Morning Coffee

8:25 Organizer's Welcome

Micah LiebermanMicah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

 

8:30 Plenary Keynote Chairperson’s Opening Remarks: Exploring the Need to Improve Clinical Trial Awareness

Kelly McKeeKelly McKee, Recruitment, Retention and Innovation Team Lead, Global Trial Optimization, Merck & Co., Inc.

The challenge of improving R&D productivity to increase the number of new therapies that advance to market tests the clinical research community every day. To ensure success in this environment, we must produce cost-effective and tangible health improvements and continue to innovate using available technologies.  Despite advances in this area, we are failing to move beyond our microcosm of those who operate in our space. A fundamental shift to include the wider ecosystem is needed to better understand the myriad of voices in clinical research to effectively develop new scientific innovations, improve business and clinical operations processes, invest in new technologies, and “get the word out”.

8:35 ROI Expectations and Objectives for Optimized Patient Awareness and Engagement

 Kenneth GetzKenneth Getz, MBA, Director, Sponsored Research Programs, Tufts CSDD; Chairman, CISCRP

There is a need with pharma and now with the ACA for a requirement in healthcare to actually do a better job of taking our customers' experience into account and into our planning. Moving beyond the concept of patient centricity, which means different things to different people depending on your role in clinical research, how do we actually do this. This presentation will focus on: (1) setting realistic expectations for patient centric initiatives, (2) establishing and measuring reasonable ROI (return-on-investment), and (3) engaging and coordinating enterprise-wide support.
 

9:00 AN INTERACTIVE MULTI-STAKEHOLDER ADVISORY PANEL: Increasing Clinical Trial Awareness:  Who, What, Where, HOW?

One of the major challenges facing clinical trial teams, sites, and patients is the lack of clinical trial awareness in the general community.  This interactive panel will take a multi-dimensional approach to bring the "voices of clinical research" into a constructive and open dialogue to explore solutions from multiple perspectives:  sponsor, site, patient, and provider.  Audience participation is not only encouraged, but mandatory!  Be prepared for a lively discussion as we explore this important challenge together.

  • How do we increase awareness of clinical research and build trust across the continuum, from the public to the PI to the patient and to our industry partners?
  • Can we move beyond the buzzword of patient centricity and figure out how to better listen to the patients/customers to inform clinical trial solutions, whether it be improved protocol design or better understanding the trial volunteer?
  • What is the ROI of patient engagement and how are CROs, Sponsors, Sites and Patients contributing or impeding real exchange?
  • Why are patients in need of experimental therapies and trial sponsors in need of trial volunteers not more easily connected? How can we reach and enroll patients for the right trial?
  • How do we design solutions that are easy for sites and patients to adopt?

Co-Moderators:

Kelly McKeeKelly McKee, Recruitment, Retention and Innovation Team Lead, Global Trial Optimization, Merck & Co., Inc. 

 

Kenneth GetzKenneth Getz, MBA, Director, Sponsored Research Programs, Tufts CSDD; Chairman, CISCRP

 

Panelists:

Joe KimJoe Kim, Senior Advisor, Clinical Development Innovation, Eli Lilly and Company

 

Mark SloanMark Sloan, M.D., Hematology & Medical Oncology, Boston Medical Center

 

Carley MedoschCarly Medosch, MBA, Chronic Illness Advocate

 

Andrew LeeAndrew Lee, M.D., Senior Vice President & Head, Global Clinical Operations, Merck & Co., Inc.

 

9:45 Grand Opening Coffee Break in the Exhibit Hall

10:45 Join Your Conference Track

Day 1 Plenary Keynote | Day 2 Plenary Keynote

Wednesday, February 24, 2016

AFTERNOON PLENARY KEYNOTES
ADVANCING CLINICAL RESEARCH WITH TECHNOLOGY AND INNOVATION  

1:30 Organizer's Welcome

Micah LiebermanMicah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

 

CLN Best Practices1:35 Plenary Keynote Chairperson’s Opening Remarks & Clinical Informatics News Best Practices Awards

Allison ProffittAllison Proffitt, Editorial Director, Bio-IT World & Clinical Informatics News

Clinical Informatics News is proud to present its 3rd Annual Clinical Informatics News Best Practices Awards. This awards program seeks to recognize outstanding examples of applied strategic innovation, partnerships, deployments, and collaborations that manifestly improve the clinical trial process.

1:50 Innovation, Technology and the Hype Cycle for Clinical Trials: From Emerging to Impact

Craig LipsetCraig Lipset, Head, Clinical Innovation, Pfizer

EMRs, big data, remote trials, sensors/wearables, social media, 3D printing… there is no shortage of opportunities and ideas that generate enthusiasm for some and trepidation for others.  Whether passed down from management or incubated upward from the internal entrepreneur, some fear getting too involved in hype while others worry about missing opportunities for true impact.  How do we separate the emerging areas to watch, the opportunities for which we need to prepare, and the areas of meaningful impact where we may be slipping behind?  Applying the hype cycle to clinical development innovation can help ground us today and prepare for tomorrow.

2:25 Adoption Of Technology Solutions In Clinical Trials: Are We Ready?

Margaretta NyilasMargaretta Nyilas, M.D., Senior Vice President, Clinical & Business Operations, OTSUKA Pharmaceutical Development & Commercialization, Inc.

Tools and technology are readily available for use in the clinical trial process, from eConsent, to eSource, to digital medicine; hence the ways in which data may be generated, collected, and processed has changed dramatically. However the emergence and adoption of technology solutions to enhance data collection and reporting to improve overall outcomes and garner operational efficiencies, has been incredibly slow in the last two decades compared to other industries. How do R&D leaders harness resources, transcend existing skill sets and truly maximize the science; a new era is upon industry - are we ready for it? … Our patients certainly are.

3:00 Refreshment Break in the Exhibit Hall (Last Chance for Viewing)      

4:00 Join Your Conference Track

Day 1 Plenary Keynote | Day 2 Plenary Keynote